In a transgenic mouse model of AD, which produces extracellular amyloid ß in the brain, reduced Glut1 levels on the surface of astrocytes weakened their ability to serve as a glucose conduit between capillaries and neurons [64,65]. Here, SLC2A1 is linked to Alzheimer disease.